Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation

Pigment Cell and Melanoma Research

Volumn 21, Issue 3, 2008, Pages 368-378

  Shin, Seung Shick ^a   Namkoong, Jin ^a   Wall, Brian A ^a   Gleason, Ryan ^a   Lee, Hwa Jin ^a   Chen, Suzie ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Glutamate signaling; Grm1; Inducible siRNA; Melanoma; Metabotropic glutamate receptor; Transformation

Indexed keywords

METABOTROPIC RECEPTOR 1; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL CULTURE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MELANOCYTES; MELANOMA; MICE; MICE, NUDE; ONCOGENES; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS;

EID: 43549096176     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00452.x     Document Type: Article

References (38)

1. Bennett, D.C., Cooper, P.J. Hart, I.R. (1987). A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int. J. Cancer 39, 414 418.
2. Busca, R., Abbe, P., Mantoux, F., Aberdam, E., Peyssonnauz, C. Ballotti, R. (2000). Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19, 2900 2910.
3. Carroll, F.Y., Stolle, A., Beart, P.M. et al. (2001). BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol. Pharmacol. 59, 965 973.
4. Cohen-Solal, K.A., Crespo-Carbone, S.M., Namkoong, J., Mackason, K.R., Roberts, K.G., Reuhl, K.R. Chen, S. (2002). Progressive appearance of pigmentation in amelanotic melanoma lesions. Pigment Cell Res. 15, 282 289.
5. Davies, H., Bignell, G.R., Cox, C. et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949 954.
6. De Blasi, A., Conn, P.J., Pin, J. Nicoletti, F. (2001). Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol. Sci. 22, 114 120.
7. Demunter, A., Stas, M., Degreef, H., De Wolf-Peeters, C. van den Oord, J.J. (2001). Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J. Invest. Dermatol. 117, 1483 1489.
8. Dotto, G.P., Moellmann, G., Ghosh, S., Edwards, M. Halaban, R. (1989). Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol. 109, 3115 3128.
9. Frati, C., Marchese, C., Fisichella, G., Copani, A., Nasca, M.R., Storto, M. Nicoletti, F. (2000). Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J. Cell. Physiol. 183, 364 372.
10. Govindarajan, B., Bai, X., Cohen, C., Zhong, H., Kilroy, S., Louis, G., Moses, M. Arbiser, J.L. (2003). Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J. Biol. Chem. 278, 9790 9795.
11. Gupta, P.B., Kuperwasser, C., Brunet, J.P., Ramaswamy, S., Kuo, W.L., Gray, J.W., Naber, S.P. Weinberg, R.A. (2005). The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 1047 1054.
12. Haas, H.S., Pfragner, R., Siegl, V., Ingolic, E., Heintz, E., Schraml, E. Schauenstein, K. (2007). The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma. Oncol. Rep. 17, 1399 1404.
13. Halaban, R. (2000). The regulation of normal melanocyte proliferation. Pigment Cell Res. 13, 4 14.
14. Hanahan, D. Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57 70.
15. Herlyn, M. Satyamoorthy, K. (1996). Activated ras. Yet another player in melanoma? Am. J. Pathol. 149, 739 744.
16. Hermans, E. Challiss, R.A. (2001). Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem. J. 359, 465 484.
17. Hinoi, E., Takarada, T., Ueshima, T., Tsuchihashi, Y. Yoneda, Y. (2004). Glutamate signaling in peripheral tissues. Eur. J. Biochem. 271, 1 13.
18. Hoogduijn, M.J., Hitchcock, I.S., Smit, N.P., Gillbro, J.M., Schallreuter, K.U. Genever, P.G. (2006). Glutamate receptors on human melanocytes regulate the expression of MiTF. Pigment Cell Res. 19, 58 67.
19. Ke, N., Albers, A., Claassen, G., Yu, D.H., Chatterton, J.E., Hu, X., Meyhack, B., Wong-Staal, F. Li, Q.X. (2004). One-week 96-well soft agar growth assay for cancer target validation. Biotechniques 36, 826 828, 830, 832-833.
20. Marin, Y.E., Namkoong, J., Cohen-Solal, K., Shin, S.S., Martino, J.J., Oka, M. Chen, S. (2006). Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell. Signal. 18, 1279 1286.
21. Matsukura, S., Jones, P.A. Takai, D. (2003). Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31, e77.
22. Namkoong, J., Shin, S.S., Lee, H.J., Marin, Y.E., Wall, B.A., Goydos, J.S. Chen, S. (2007). Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res. 67, 2298 2305.
23. Ortiz, P., Vanaclocha, F., Lopez-Bran, E. et al. (2007). Genetic analysis of the GRM1 gene in human melanoma susceptibility. Eur. J. Hum. Genet. 15, 1176 1182.
24. Owen, J.D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R. Richmond, A. (1997). Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int. J. Cancer 73, 94 103.
25. Pin, J.-P. Duvoisin, R. (1995). The metabotropic glutamate receptors: structure and functions. Neuropharmcology 34, 1 26.
26. Pollock, P.M., Cohen-Solal, K., Sood, R. et al. (2003). Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat. Genet. 34, 108 112.
27. Rzeski, W., Turski, L. Ikonomidou, C. (2001). Glutamate antagonists limit tumor growth. Proc. Natl. Acad. Sci. USA 98, 6372 6377.
28. Satyamoorthy, K., Li, G., Gerrero, M.R., Brose, M.S., Volpe, P., Weber, B.L., Van Belle, P., Elder, D.E. Herlyn, M. (2003). Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 63, 756 759.
29. Shin, S.I., Freedman, V.H., Risser, R. Pollack, R. (1975). Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. USA 72, 4435 4439.
30. Skerry, T.M. Genever, P.G. (2001). Glutamate signalling in non-neuronal tissues. Trends Pharmacol. Sci. 22, 174 181.
31. Stepulak, A., Sifringer, M., Rzeski, W. et al. (2005). NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc. Natl. Acad. Sci. USA 102, 15605 15610.
32. Sviderskaya, E.V., Hill, S.P., Evans-Whipp, T.J., Chin, L., Orlow, S.J., Easty, D.J., Cheong, S.C., Beach, D., DePinho, R.A. Bennett, D.C. (2002). p16(Ink4a) in melanocyte senescence and differentiation. J. Natl. Cancer Inst. 94, 446 454.
33. Takano, T., Lin, J.H., Arcuino, G., Gao, Q., Yang, J. Nedergaard, M. (2001). Glutamate release promotes growth of malignant gliomas. Nat. Med. 7, 1010 1015.
34. Wang, D., Yang, W., Du, J., Devalaraja, M.N., Liang, P., Matsumoto, K., Tsubakimoto, K., Endo, T. Richmond, A. (2000). MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19, 4647 4659.
35. Wellbrock, C., Ogilvie, L., Hedley, D., Karasarides, M., Martin, J., Niculescu-Duvaz, D., Springer, C.J. Marais, R. (2004). V599EB-RAF is an oncogene in melanocytes. Cancer Res. 64, 2338 2342.
36. Whitwam, T., Vanbrocklin, M.W., Russo, M.E., Haak, P.T., Bilgili, D., Resau, J.H., Koo, H.M. Holmen, S.L. (2007). Differential oncogenic potential of activated RAS isoforms in melanocytes. Oncogene 26, 4563 4570.
37. Zhu, H., Reuhl, K., Zhang, X., Botha, R., Ryan, K., Wei, J. Chen, S. (1998). Development of heritable melanoma in transgenic mice. J. Invest. Dermatol. 110, 247 252.
38. Zhu, H., Ryan, K. Chen, S. (1999). Cloning of novel splice variants of mouse mGluR1. Brain Res. Mol. Brain Res. 73, 93 103.